We’ll close out the week with the well-titled BioLawGics, a blog by the Life Sciences team at Dechert devoted to exploring the legal aspects of bringing biological medicines to market. Recent posts have discussed such topics as Biosimilars Guidance, the Biologics Price Competition Act, and diagnostic test patenting, among others.